{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:33:07Z","timestamp":1790663587070,"version":"4.1.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Hematol Oncol"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1186\/1756-8722-4-50","type":"journal-article","created":{"date-parts":[[2011,12,9]],"date-time":"2011-12-09T07:28:11Z","timestamp":1323415691000},"source":"Crossref","is-referenced-by-count":85,"title":["The Four types of Tregs in malignant lymphomas"],"prefix":"10.1186","volume":"4","author":[{"given":"Jing","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Yan","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,12,9]]},"reference":[{"key":"183_CR1","doi-asserted-by":"publisher","first-page":"986","DOI":"10.2741\/3657","volume":"15","author":"J Mai","year":"2010","unstructured":"Mai J, Wang H, Yang XF: Th 17 cells interplay with Foxp3+ Tregs in regulation of inflammation and autoimmunity. Front Biosci. 2010, 15: 986-1006. 10.2741\/3657.","journal-title":"Front Biosci"},{"key":"183_CR2","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1034\/j.1600-065X.2001.1820102.x","volume":"182","author":"S Sakaguchi","year":"2001","unstructured":"Sakaguchi S, Sakaguchi N, Shimizu J, Yamazaki S, Sakihama T, Itoh M, Kuniyasu Y, Nomura T, Toda M, Takahashi T: Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol Rev. 2001, 182: 18-32. 10.1034\/j.1600-065X.2001.1820102.x.","journal-title":"Immunol Rev"},{"key":"183_CR3","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1002\/1521-4141(200104)31:4<1122::AID-IMMU1122>3.0.CO;2-P","volume":"31","author":"LS Taams","year":"2001","unstructured":"Taams LS, Smith J, Rustin MH, Salmon M, Poulter LW, Akbar AN: Human anergic\/suppressive CD4+CD25+ T cells: a highly differentiated and apoptosis-prone population. Eur J Immunol. 2001, 31: 1122-31. 10.1002\/1521-4141(200104)31:4<1122::AID-IMMU1122>3.0.CO;2-P.","journal-title":"Eur J Immunol"},{"key":"183_CR4","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/nri821","volume":"2","author":"EM Shevach","year":"2002","unstructured":"Shevach EM: CD4+CD25+ suppressor T cells: more questions than answers. Nat Rev Immunol. 2002, 2: 389-400.","journal-title":"Nat Rev Immunol"},{"issue":"26","key":"183_CR5","doi-asserted-by":"publisher","first-page":"6358","DOI":"10.1200\/JCO.2005.26.856","volume":"23","author":"D de Jong","year":"2005","unstructured":"de Jong D: Molecular pathogenesis of follicular lymphoma: a cross talk of genetic and immunologic factors. J Clin Oncol. 2005, 23 (26): 6358-63. 10.1200\/JCO.2005.26.856.","journal-title":"J Clin Oncol"},{"issue":"3","key":"183_CR6","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1586\/14737140.5.3.477","volume":"5","author":"J Drach","year":"2005","unstructured":"Drach J, Seidl S, Kaufmann H: Treatment of mantle cell lymphoma: targeting the microenvironment. Expert Rev Anticancer Ther. 2005, 5 (3): 477-85. 10.1586\/14737140.5.3.477.","journal-title":"Expert Rev Anticancer Ther"},{"issue":"3","key":"183_CR7","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1200\/JCO.2001.19.3.720","volume":"19","author":"SM Ansell","year":"2001","unstructured":"Ansell SM, Stenson M, Habermann TM: CD4+ T-cell immune response to large B-cell non-Hodgkin's lymphoma predicts patient outcome. J Clin Oncol. 2001, 19 (3): 720-6.","journal-title":"J Clin Oncol"},{"key":"183_CR8","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1146\/annurev.immunol.21.120601.141122","volume":"22","author":"S Sakaguchi","year":"2004","unstructured":"Sakaguchi S: Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol. 2004, 22: 531-562. 10.1146\/annurev.immunol.21.120601.141122.","journal-title":"Annu Rev Immunol"},{"issue":"8","key":"183_CR9","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1084\/jem.20051511","volume":"202","author":"F Ghiringhelli","year":"2005","unstructured":"Ghiringhelli F, M\u00e9nard C, Terme M, Flament C, Taieb J, Chaput N, Puig PE, Novault S, Escudier B, Vivier E, Lecesne A, Robert C, Blay JY, Bernard J, Caillat-Zucman S, Freitas A, Tursz T, Wagner-Ballon O, Capron C, Vainchencker W, Martin F, Zitvogel L: CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner. J Exp Med. 2005, 202 (8): 1075-85. 10.1084\/jem.20051511.","journal-title":"J Exp Med"},{"issue":"1","key":"183_CR10","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1189\/jlb.0606409","volume":"81","author":"N Ralainirina","year":"2007","unstructured":"Ralainirina N, Poli A, Michel T, Poos L, Andr\u00e8s E, Hentges F, Zimmer J: Control of NK cell functions by CD4+CD25+ regulatory T cells. J Leukoc Biol. 2007, 81 (1): 144-53.","journal-title":"J Leukoc Biol"},{"key":"183_CR11","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/j.1600-065X.2006.00445.x","volume":"214","author":"F Ghiringhelli","year":"2006","unstructured":"Ghiringhelli F, Menard C, Martin F, Zitvogel L: The role of regulatory T cells in the control of natural killer cells: relevance during tumor progression. Immunol Rev. 2006, 214: 229-238. 10.1111\/j.1600-065X.2006.00445.x.","journal-title":"Immunol Rev"},{"key":"183_CR12","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1756-8722-2-34","volume":"2","author":"S Han","year":"2009","unstructured":"Han S, Huang Y, Liang Y, Ho Y, Wang Y, Chang LJ: Phenotype and functional evaluation of ex vivo generated antigen-specific immune effector cells with potential for therapeutic applications. J Hematol Oncol. 2009, 2: 34-10.1186\/1756-8722-2-34.","journal-title":"J Hematol Oncol"},{"key":"183_CR13","first-page":"3986","volume":"13","author":"X Ke","year":"2008","unstructured":"Ke X, Wang J, Li L, Chen IH, Wang H, Yang XF: Roles of CD4+CD25(high) FOXP3+ Tregs in lymphomas and tumors are complex. Front Biosci. 2008, 13: 3986-4001.","journal-title":"Front Biosci"},{"key":"183_CR14","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.2741\/2775","volume":"13","author":"XF Yang","year":"2008","unstructured":"Yang XF: Factors regulating apoptosis and homeostasis of CD4+ CD25(high) FOXP3+ regulatory T cells are new therapeutic targets. Front Biosci. 2008, 13: 1472-99. 10.2741\/2775.","journal-title":"Front Biosci"},{"issue":"1","key":"183_CR15","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1756-8722-4-31","volume":"4","author":"ZL Wu","year":"2011","unstructured":"Wu ZL, Song YQ, Shi YF, Zhu J: High nuclear expression of STAT3 is associated with unfavorable prognosis in diffuse large B-cell lymphoma. J Hematol Oncol. 2011, 4 (1): 31-10.1186\/1756-8722-4-31.","journal-title":"J Hematol Oncol"},{"issue":"3","key":"183_CR16","first-page":"181","volume":"56","author":"A Kosmaczewska","year":"2008","unstructured":"Kosmaczewska A, Ciszak L, Potoczek S, Frydecka I: The significance of Treg cells in defective tumor immunity. ArchImmunolTherExp (Warsz). 2008, 56 (3): 181-91.","journal-title":"ArchImmunolTherExp (Warsz)"},{"key":"183_CR17","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1200\/JCO.2001.19.3.720","volume":"19","author":"SM Ansell","year":"2001","unstructured":"Ansell SM, Stenson M, Habermann TM, Jelinek DF, Witzig TE: CD4+T cell immune responseto large B-cell non-Hodgkin'slymphomapredictspatientoutcome. J Clin Oncol. 2001, 19: 720-726.","journal-title":"J Clin Oncol"},{"key":"183_CR18","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/3-540-27702-1_13","volume":"293","author":"T Nomura","year":"2005","unstructured":"Nomura T, Sakaguchi S: Naturally arising CD25+CD4+ regulatory T cells in tumor immunity. Curr Top Microbiol Immunol. 2005, 293: 287-302. 10.1007\/3-540-27702-1_13.","journal-title":"Curr Top Microbiol Immunol"},{"issue":"12","key":"183_CR19","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1038\/sj.leu.2403965","volume":"19","author":"G Roncador","year":"2005","unstructured":"Roncador G, Garcia JF, Garcia JF, Maestre L, Lucas E, Menarguez J, Ohshima K, Nakamura S, Banham AH, Piris MA: FOXP3, a selective marker for a subset of adult T-cell leukaemia\/lymphoma. Leukemia. 2005, 19 (12): 2247-53. 10.1038\/sj.leu.2403965.","journal-title":"Leukemia"},{"issue":"12","key":"183_CR20","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1038\/jid.2009.290","volume":"129","author":"RA Clark","year":"2009","unstructured":"Clark RA: Regulation gone wrong: a subset of S\u00e9zary patients have malignant regulatory T cells. J Invest Dermatol. 2009, 129 (12): 2747-50. 10.1038\/jid.2009.290.","journal-title":"J Invest Dermatol"},{"issue":"2","key":"183_CR21","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3324\/haematol.11702","volume":"93","author":"A Tzankov","year":"2008","unstructured":"Tzankov A, Meier C, Hirschmann P, Went P, Pileri SA, Dirnhofer S: Correlation of high numbers of intratumoral FOXP3+ regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin's lymphoma. Haematologica. 2008, 93 (2): 193-200. 10.3324\/haematol.11702.","journal-title":"Haematologica"},{"issue":"2","key":"183_CR22","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1080\/10428190701824536","volume":"49","author":"NR Lee","year":"2008","unstructured":"Lee NR, Song EK, Jang KY, Choi HN, Moon WS, Kwon K, Lee JH, Yim CY, Kwak JY: Prognostic impact of tumor infiltrating FOXP3 positive regulatory T cells in diffuse large B-cell lymphoma at diagnosis. Leuk Lymphoma. 2008, 49 (2): 247-56. 10.1080\/10428190701824536.","journal-title":"Leuk Lymphoma"},{"issue":"2","key":"183_CR23","doi-asserted-by":"publisher","first-page":"570","DOI":"10.2353\/ajpath.2010.100150","volume":"177","author":"J Bruneau","year":"2010","unstructured":"Bruneau J, Canioni D, Renand A, Marafioti T, Paterson JC, Martin-Garcia N, Gaulard P, Delfau MH, Hermine O, Macintyre E, Brousse N, Asnafi V: Regulatory T-cell depletion in angioimmunoblastic T-cell lymphoma. Am J Pathol. 2010, 177 (2): 570-4. 10.2353\/ajpath.2010.100150.","journal-title":"Am J Pathol"},{"issue":"11","key":"183_CR24","first-page":"1186","volume":"28","author":"H Lin","year":"2009","unstructured":"Lin H, Sun XF, Zhen ZJ, Xia Y, Ling JY, Huang HQ, Xia ZJ, Lin TY: Correlation between peripheral blood CD4+CD25high CD127low regulatory T cell and clinical characteristics of patients with non-Hodgkin's lymphoma. Ai Zheng. 2009, 28 (11): 1186-92.","journal-title":"Ai Zheng"},{"issue":"11","key":"183_CR25","doi-asserted-by":"publisher","first-page":"5359","DOI":"10.1182\/blood-2007-08-105395","volume":"111","author":"S Mittal","year":"2008","unstructured":"Mittal S, Marshall NA, Duncan L, Culligan DJ, Barker RN, Vickers MA: Local and systemic induction of CD4+CD25+ regulatory T-cell population by non-Hodgkin lymphoma. Blood. 2008, 111 (11): 5359-70. 10.1182\/blood-2007-08-105395.","journal-title":"Blood"},{"key":"183_CR26","doi-asserted-by":"publisher","first-page":"10145","DOI":"10.1158\/0008-5472.CAN-06-1822","volume":"66","author":"ZZ Yang","year":"2006","unstructured":"Yang ZZ, Novak AJ, Ziesmer SC, Witzig TE, Ansell SM: Attenuation of CD8(+) T-cell functionby CD4(+)CD25(+) regulatory T cells in B-cell non-Hodgkin's lymphoma. Cancer Res. 2006, 66: 10145-10152. 10.1158\/0008-5472.CAN-06-1822.","journal-title":"Cancer Res"},{"key":"183_CR27","doi-asserted-by":"publisher","first-page":"4051","DOI":"10.4049\/jimmunol.178.7.4051","volume":"178","author":"SP Hilchey","year":"2007","unstructured":"Hilchey SP, De A, Rimsza LM, Bankert RB, Bernstein SH: Follicular lymphoma intratumoral CD4+CD25+GITR+ regulatory T cells potently suppress CD3\/CD28-costimulated autologous and allogeneic CD8+CD25- and CD4+CD25- T cells. J Immunol. 2007, 178: 4051-4061.","journal-title":"J Immunol"},{"issue":"6","key":"183_CR28","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1007\/s10875-011-9584-9","volume":"31","author":"LL Feng","year":"2011","unstructured":"Feng LL, Gao JM, Li PP, Wang X: IL-9 Contributes to Immunosuppression Mediated by Regulatory T Cells and Mast Cells in B-Cell Non-Hodgkin's Lymphoma. J Clin Immunol. 2011, 31 (6): 1084-94. 10.1007\/s10875-011-9584-9.","journal-title":"J Clin Immunol"},{"issue":"3","key":"183_CR29","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/j.1365-2567.2010.03308.x","volume":"131","author":"CA Lindqvist","year":"2010","unstructured":"Lindqvist CA, Christiansson LH, Simonsson B, Enblad G, Olsson-Str\u00f6mberg U, Loskog AS: T regulatory cells control T-cell proliferation partly by the release of soluble CD25 in patients with B-cell malignancies. Immunology. 2010, 131 (3): 371-6. 10.1111\/j.1365-2567.2010.03308.x.","journal-title":"Immunology"},{"key":"183_CR30","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/349254a0","volume":"349","author":"TJ McDonnell","year":"1991","unstructured":"McDonnell TJ, Korsmeyer SJ: Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14; 18). Nature. 1991, 349: 254-256. 10.1038\/349254a0.","journal-title":"Nature"},{"key":"183_CR31","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1056\/NEJMoa041869","volume":"351","author":"SS Dave","year":"2004","unstructured":"Dave SS, Wright G, Tan B, Rosenwald A, Gascoyne RD, Chan WC, Fisher RI, Braziel RM, Rimsza LM, Grogan TM, Miller TP, LeBlanc M, Greiner TC, Weisenburger DD, Lynch JC, Vose J, Armitage JO, Smeland EB, Kvaloy S, Holte H, Delabie J, Connors JM, Lansdorp PM, Ouyang Q, Lister TA, Davies AJ, Norton AJ, Muller-Hermelink HK, Ott G, Campo E, Montserrat E, Wilson WH, Jaffe ES, Simon R, Yang L, Powell J, Zhao H, Goldschmidt N, Chiorazzi M, Staudt LM: Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. N Engl J Med. 2004, 351: 2159-2169. 10.1056\/NEJMoa041869.","journal-title":"N Engl J Med"},{"key":"183_CR32","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1172\/JCI19441","volume":"112","author":"MR Walker","year":"2003","unstructured":"Walker MR, Kasprowicz DJ, Gersuk VH, Benard A, Van Landeghen M, Buckner JH, Ziegler SF: Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells. The Journal of clinical investigation. 2003, 112: 1437-43.","journal-title":"The Journal of clinical investigation"},{"key":"183_CR33","doi-asserted-by":"publisher","first-page":"4433","DOI":"10.4049\/jimmunol.173.7.4433","volume":"173","author":"EA Moseman","year":"2004","unstructured":"Moseman EA, Liang X, Dawson AJ, Panoskaltsis-Mortari A, Krieg AM, Liu Y-J, Blazar BR, Chen W: Human Plasmacytoid Dendritic Cells Activated by CpGOligodeoxynucleotides Induce the Generation of CD4+CD25+ Regulatory T Cells. J Immunol. 2004, 173: 4433-42.","journal-title":"J Immunol"},{"key":"183_CR34","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1084\/jem.20061660","volume":"204","author":"T Ito","year":"2007","unstructured":"Ito T, Yang M, Wang Y-H, Lande R, Gregorio J, Perng OA, Qin X-F, Liu Y-J, Gilliet M: Plasmacytoid dendritic cells prime IL-10-producing T regulatory cells by inducible costimulator ligand. J Exp Med. 2007, 204: 105-15. 10.1084\/jem.20061660.","journal-title":"J Exp Med"},{"key":"183_CR35","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1182\/blood.V110.11.537.537","volume":"110","author":"Z-Z Yang","year":"2007","unstructured":"Yang Z-Z, Novak AJ, Ziesmer SC, Witzig TE, Ansell SM: CD70+ non-Hodgkin lymphoma B cells induce Foxp3 expression and regulatory function in intratumoral CD4+CD25- T cells. Blood. 2007, 110: 537-44.","journal-title":"Blood"},{"issue":"1","key":"183_CR36","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1002\/ijc.23881","volume":"124","author":"WZ Ai","year":"2009","unstructured":"Ai WZ, Hou JZ, Zeiser R, Czerwinski D, Negrin RS, Levy R: Follicular lymphoma B cells induce the conversion of conventional CD4+ T cells to T-regulatory cells. Int J Cancer. 2009, 124 (1): 239-44. 10.1002\/ijc.23881.","journal-title":"Int J Cancer"},{"issue":"9","key":"183_CR37","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.1182\/blood-2006-04-018218","volume":"108","author":"J Carreras","year":"2006","unstructured":"Carreras J, Lopez-Guillermo A, Fox BC, Colomo L, Martinez A, Roncador G, Montserrat E, Campo E, Banham AH: High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma. Blood. 2006, 108 (9): 2957-64. 10.1182\/blood-2006-04-018218.","journal-title":"Blood"},{"key":"183_CR38","volume-title":"Appl Immuno histochem Mol Morphol","author":"BE Beltran","year":"2011","unstructured":"Beltran BE, Morales D, Quinones P, Miranda RN, Goswami M, Castillo JJ: Peripheral T-cell Lymphoma With a Regulatory T-cell Phenotype: Report of a Nodal and an Extranodal Case From Peru. Appl Immuno histochem Mol Morphol. 2011,"},{"issue":"1","key":"183_CR39","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/j.1349-7006.2010.01767.x","volume":"102","author":"T Ishida","year":"2011","unstructured":"Ishida T, Ueda R: Immunopathogenesis of lymphoma: focus on CCR4. Cancer Sci. 2011, 102 (1): 44-50. 10.1111\/j.1349-7006.2010.01767.x.","journal-title":"Cancer Sci"},{"key":"183_CR40","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/B978-0-12-385524-4.00004-0","volume":"111","author":"CR Bangham","year":"2011","unstructured":"Bangham CR, Toulza F: Adult T cell leukemia\/lymphoma: FoxP3(+) cells and the cell-mediated immune response to HTLV-1. Adv Cancer Res. 2011, 111: 163-82.","journal-title":"Adv Cancer Res"},{"issue":"12","key":"183_CR41","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1038\/jid.2009.290","volume":"129","author":"RA Clark","year":"2009","unstructured":"Clark RA: Regulation gone wrong: a subset of S\u00e9zary patients have malignant regulatory T cells. J Invest Dermatol. 2009, 129 (12): 2747-50. 10.1038\/jid.2009.290.","journal-title":"J Invest Dermatol"},{"issue":"12","key":"183_CR42","doi-asserted-by":"publisher","first-page":"2512","DOI":"10.1038\/sj.leu.2404913","volume":"21","author":"LM Gjerdrum","year":"2007","unstructured":"Gjerdrum LM, Woetmann A, Odum N, Burton CM, Rossen K, Skovgaard GL, Ryder LP, Ralfkiaer E: FOXP3+ regulatory T cells in cutaneous T-cell lymphomas: association with disease stage and survival. Leukemia. 2007, 21 (12): 2512-8. 10.1038\/sj.leu.2404913.","journal-title":"Leukemia"},{"issue":"8","key":"183_CR43","first-page":"e95","volume":"19","author":"AC Knol","year":"2010","unstructured":"Knol AC, Qu\u00e9reux G, Brocard A, Ballanger F, Khammari A, Nguyen JM, Dr\u00e9no B: Absence of modulation of CD4+CD25 regulatory T cells in CTCL patients treated with bexarotene. ExpDermatol. 2010, 19 (8): e95-102.","journal-title":"ExpDermatol"},{"issue":"5","key":"183_CR44","first-page":"535","volume":"37","author":"DA Wada","year":"2010","unstructured":"Wada DA, Wilcox RA, Weenig RH, Gibson LE: Paucity of intraepidermal FoxP3-positive T cells in cutaneous T-cell lymphoma in contrast with spongiotic and lichenoid dermatitis. J CutanPathol. 2010, 37 (5): 535-41.","journal-title":"J CutanPathol"},{"issue":"12","key":"183_CR45","doi-asserted-by":"publisher","first-page":"2875","DOI":"10.1038\/jid.2009.175","volume":"129","author":"JB Heid","year":"2009","unstructured":"Heid JB, Schmidt A, Oberle N, Goerdt S, Krammer PH, Suri-Payer E, Klemke CD: FOXP3+CD25- tumor cells with regulatory function in S\u00e9zary syndrome. J Invest Dermatol. 2009, 129 (12): 2875-85. 10.1038\/jid.2009.175.","journal-title":"J Invest Dermatol"},{"issue":"2","key":"183_CR46","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1177\/039463200902200212","volume":"22","author":"P Quaglino","year":"2009","unstructured":"Quaglino P, Comessatti A, Ponti R, Peroni A, Mola F, Fierro MT, Savoia P, Novelli M, Bernengo MG: Reciprocal modulation of circulating CD4+CD25+bright T cells induced by extracorporeal photochemotherapy in cutaneous T-cell lymphoma and chronic graft-versus-host-disease patients. Int J Immunopathol Pharmacol. 2009, 22 (2): 353-62.","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"10","key":"183_CR47","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1038\/sj.jid.5700371","volume":"126","author":"MM Tiemessen","year":"2006","unstructured":"Tiemessen MM, Mitchell TJ, Hendry L, Whittaker SJ, Taams LS, John S: Lack of suppressive CD4+CD25+FOXP3+ T cells in advanced stages of primary cutaneous T-cell lymphoma. J Invest Dermatol. 2006, 126 (10): 2217-23. 10.1038\/sj.jid.5700371.","journal-title":"J Invest Dermatol"},{"issue":"12","key":"183_CR48","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1038\/leu.2008.224","volume":"22","author":"T Krejsgaard","year":"2008","unstructured":"Krejsgaard T, Gjerdrum LM, Ralfkiaer E, Lauenborg B, Eriksen KW, Mathiesen AM, Bovin LF, Gniadecki R, Geisler C, Ryder LP, Zhang Q, Wasik MA, Odum N, Woetmann A: Malignant Tregs express low molecular splice forms of FOXP3 in S\u00e9zary syndrome. Leukemia. 2008, 22 (12): 2230-9. 10.1038\/leu.2008.224.","journal-title":"Leukemia"},{"key":"183_CR49","first-page":"285","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"JKC Chan","year":"2008","unstructured":"Chan JKC, Quintanilla-Martinez L, Ferry JA, Peh SC: Extranodal NK\/T-cell lymphoma, nasal type. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Edited by: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW. 2008, Lyon, France: IARC Press, 285-288. 4","edition":"4"},{"issue":"7","key":"183_CR50","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.7150\/ijbs.7.1027","volume":"7","author":"RJ Peng","year":"2011","unstructured":"Peng RJ, Huang ZF, Zhang YL, Yuan ZY, Xia Y, Jiang WQ, Zeng YX, Li J: Circulating and tumor-infiltrating Foxp3+ regulatory T cell subset in Chinese patients with extranodal NK\/T cell lymphoma. Int J Biol Sci. 2011, 7 (7): 1027-36.","journal-title":"Int J Biol Sci"},{"issue":"10","key":"183_CR51","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1093\/annonc\/mdp056","volume":"20","author":"WY Kim","year":"2009","unstructured":"Kim WY, Jeon YK, Kim TM, Kim JE, Kim YA, Lee SH, Kim DW, Heo DS, Kim CW: Increased quantity of tumor-infiltrating FOXP3-positive regulatory T cells is an independent predictor for improved clinical outcome in extranodal NK\/T-cell lymphoma. Ann Oncol. 2009, 20 (10): 1688-96. 10.1093\/annonc\/mdp056.","journal-title":"Ann Oncol"},{"issue":"4","key":"183_CR52","first-page":"613","volume":"130","author":"I Bonzheim","year":"2008","unstructured":"Bonzheim I, Geissinger E, Tinguely M, Roth S, Grieb T, Reimer P, Wilhelm M, Rosenwald A, M\u00fcller-Hermelink HK, R\u00fcdiger T: Evaluation of FoxP3 expression in peripheral T-cell lymphoma. Am J ClinPathol. 2008, 130 (4): 613-9.","journal-title":"Am J ClinPathol"},{"issue":"2","key":"183_CR53","doi-asserted-by":"publisher","first-page":"570","DOI":"10.2353\/ajpath.2010.100150","volume":"177","author":"J Bruneau","year":"2010","unstructured":"Bruneau J, Canioni D, Renand A, Marafioti T, Paterson JC, Martin-Garcia N, Gaulard P, Delfau MH, Hermine O, Macintyre E, Brousse N, Asnafi V: Regulatory T-cell depletion in angioimmunoblastic T-cell lymphoma. Am J Pathol. 2010, 177 (2): 570-4. 10.2353\/ajpath.2010.100150.","journal-title":"Am J Pathol"},{"key":"183_CR54","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.immuni.2009.03.019","volume":"30","author":"M Miyara","year":"2009","unstructured":"Miyara M, Yoshioka Y, Kitoh A, Shima T, Wing K, Niwa A, Parizot C, Taflin C, Heike T, Valeyre D, Mathian A, Nakahata T, Yamaguchi T, Nomura T, Ono M, Amoura Z, Gorochov G, Sakaguchi S: Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor. Immunity. 2009, 30: 899-911. 10.1016\/j.immuni.2009.03.019.","journal-title":"Immunity"},{"key":"183_CR55","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1097\/01.pas.0000209855.28282.ce","volume":"30","author":"DM Dorfman","year":"2006","unstructured":"Dorfman DM, Brown JA, Shahsafaei A, Freeman GJ: Programmed death-1 (PD-1) is a marker of germinal center-associated T cells and angioimmunoblastic T-cell lymphoma. Am J SurgPathol. 2006, 30: 802-810.","journal-title":"Am J SurgPathol"},{"issue":"6","key":"183_CR56","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1111\/j.1600-0609.2008.01064.x","volume":"80","author":"LM Gjerdrum","year":"2008","unstructured":"Gjerdrum LM, Woetmann A, Odum N, Hother C, Henrik-Nielsen R, Gniadecki R, Ralfkiaer E: FOXP3 positive regulatory T-cells in cutaneous and systemic CD30 positive T-cell lymphoproliferations. Eur J Haematol. 2008, 80 (6): 483-9. 10.1111\/j.1600-0609.2008.01064.x.","journal-title":"Eur J Haematol"},{"key":"183_CR57","doi-asserted-by":"publisher","first-page":"9964","DOI":"10.1073\/pnas.0603507103","volume":"103","author":"M Kasprzycka","year":"2006","unstructured":"Kasprzycka M, Marzec M, Liu X, Zhang Q, Wasik MA: Nucleophosmin\/anaplastic lymphoma kinase (NPM\/ALK) oncoprotein induces the T regulatory cell phenotype by activating STAT3. ProcNatlAcadSci USA. 2006, 103: 9964-9969. 10.1073\/pnas.0603507103.","journal-title":"ProcNatlAcadSci USA"},{"issue":"11","key":"183_CR58","doi-asserted-by":"publisher","first-page":"5716","DOI":"10.1158\/0008-5472.CAN-06-0261","volume":"66","author":"T Ishida","year":"2006","unstructured":"Ishida T, Ishii T, Inagaki A, Yano H, Komatsu H, Iida S, Inagaki H, Ueda R: Specific recruitment of CC chemokine receptor 4-positive regulatory T cells in Hodgkin lymphoma fosters immune privilege. Cancer Res. 2006, 66 (11): 5716-22. 10.1158\/0008-5472.CAN-06-0261.","journal-title":"Cancer Res"},{"issue":"6","key":"183_CR59","first-page":"958","volume":"128","author":"TW Kelley","year":"2007","unstructured":"Kelley TW, Pohlman B, Elson P, Hsi ED: The ratio of FOXP3+ regulatory T cells to granzyme B+ cytotoxic T\/NK cells predicts prognosis in classical Hodgkin lymphoma and is independent of bcl-2 and MAL expression. Am J ClinPathol. 2007, 128 (6): 958-65.","journal-title":"Am J ClinPathol"},{"issue":"1","key":"183_CR60","first-page":"31","volume":"27","author":"S Schreck","year":"2009","unstructured":"Schreck S, Friebel D, Buettner M, Distel L, Grabenbauer G, Young LS, Niedobitek G: Prognostic impact of tumour-infiltrating Th2 and regulatory T cells in classical Hodgkin lymphoma. HematolOncol. 2009, 27 (1): 31-9.","journal-title":"HematolOncol"},{"issue":"1","key":"183_CR61","doi-asserted-by":"publisher","first-page":"195","DOI":"10.2353\/ajpath.2008.070845","volume":"173","author":"KR Baumforth","year":"2008","unstructured":"Baumforth KR, Birgersdotter A, Reynolds GM, Wei W, Kapatai G, Flavell JR, Kalk E, Piper K, Lee S, Machado L, Hadley K, Sundblad A, Sjoberg J, Bjorkholm M, Porwit AA, Yap LF, Teo S, Grundy RG, Young LS, Ernberg I, Woodman CB, Murray PG: Expression of the Epstein-Barr virus-encoded Epstein-Barr virus nuclear antigen 1 in Hodgkin's lymphoma cells mediates Up-regulation of CCL20 and the migration of regulatory T cells. Am J Pathol. 2008, 173 (1): 195-204. 10.2353\/ajpath.2008.070845.","journal-title":"Am J Pathol"},{"issue":"8","key":"183_CR62","doi-asserted-by":"publisher","first-page":"3339","DOI":"10.1182\/blood-2008-01-134783","volume":"112","author":"B Lamprecht","year":"2008","unstructured":"Lamprecht B, Kreher S, Anagnostopoulos I, J\u00f6hrens K, Monteleone G, Jundt F, Stein H, Janz M, D\u00f6rken B, Mathas S: Aberrant expression of the Th2 cytokine IL-21 in Hodgkin lymphoma cells regulates STAT3 signaling and attracts Treg cells via regulation of MIP-3alpha. Blood. 2008, 112 (8): 3339-47. 10.1182\/blood-2008-01-134783.","journal-title":"Blood"},{"issue":"1","key":"183_CR63","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00262-010-0918-x","volume":"60","author":"M Warncke","year":"2011","unstructured":"Warncke M, Buchner M, Thaller G, Dodero A, Bulashevska A, Pfeifer D, Timmer J, Veelken H: Control of the specificity of T cell-mediated anti-idiotype immunity by natural regulatory T cells. Cancer Immunol Immunother. 2011, 60 (1): 49-60. 10.1007\/s00262-010-0918-x.","journal-title":"Cancer Immunol Immunother"},{"issue":"4","key":"183_CR64","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1002\/eji.200939513","volume":"40","author":"K Ohkusu-Tsukada","year":"2010","unstructured":"Ohkusu-Tsukada K, Toda M, Udono H, Kawakami Y, Takahashi K: Targeted inhibition of IL-10-secreting CD25- Treg via p38 MAPK suppression in cancer immunotherapy. Eur J Immunol. 2010, 40 (4): 1011-21. 10.1002\/eji.200939513.","journal-title":"Eur J Immunol"},{"issue":"5","key":"183_CR65","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1002\/ijc.25132","volume":"127","author":"IE Galani","year":"2010","unstructured":"Galani IE, Wendel M, Stojanovic A, Jesiak M, M\u00fcller MM, Schellack C, Suri-Payer E, Cerwenka A: Regulatory T cells control macrophage accumulation and activation in lymphoma. Int J Cancer. 2010, 127 (5): 1131-40.","journal-title":"Int J Cancer"},{"issue":"4","key":"183_CR66","first-page":"596","volume":"35","author":"NA Marshall","year":"2007","unstructured":"Marshall NA, Culligan DJ, Tighe J, Johnston PW, Barker RN, Vickers MA: The relationships between Epstein-Barr virus latent membrane protein 1 and regulatory T cells in Hodgkin's lymphoma. ExpHematol. 2007, 35 (4): 596-604.","journal-title":"ExpHematol"},{"issue":"5","key":"183_CR67","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.intimp.2009.01.015","volume":"9","author":"J Li","year":"2009","unstructured":"Li J, Qian CN, Zeng YX: Regulatory T cells and EBV associated malignancies. Int Immunopharmacol. 2009, 9 (5): 590-2. 10.1016\/j.intimp.2009.01.015.","journal-title":"Int Immunopharmacol"}],"container-title":["Journal of Hematology &amp; Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1756-8722-4-50.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1756-8722-4-50\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1756-8722-4-50.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,28]],"date-time":"2020-06-28T14:37:22Z","timestamp":1593355042000},"score":1,"resource":{"primary":{"URL":"https:\/\/jhoonline.biomedcentral.com\/articles\/10.1186\/1756-8722-4-50"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":67,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["183"],"URL":"https:\/\/doi.org\/10.1186\/1756-8722-4-50","relation":{},"ISSN":["1756-8722"],"issn-type":[{"value":"1756-8722","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12]]},"article-number":"50"}}